Motor neuron-specific overexpression of the presynaptic choline transporter: Impact on motor endurance and evoked muscle activity

Neuroscience

Volumn 171, Issue 4, 2010, Pages 1041-1053

  Lund, D ^a   Ruggiero, A M ^a   Ferguson, S M ^a   Wright, J ^a   English, B A ^a   Reisz, P A ^a   Whitaker, S M ^a   Peltier, A C ^a   Blakely, R D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; Choline; Neuromuscular; Synapse; Transgenic; Transport

Indexed keywords

ACETYLCHOLINE; CHOLINE; CHOLINE ACETYLTRANSFERASE; COMPLEMENTARY DNA;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYNAPSE; CONTROLLED STUDY; ENDURANCE; ENZYME ACTIVITY; EVOKED MUSCLE RESPONSE; GENOTYPE; HYPOGLOSSAL NUCLEUS; IMMUNOBLOTTING; IMMUNOREACTIVITY; MOTONEURON; MOUSE; MUSCLE ACTION POTENTIAL; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENE; TREADMILL EXERCISE;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN; CHOLINE O-ACETYLTRANSFERASE; ELECTRIC STIMULATION; EXERCISE TEST; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GPI-LINKED PROTEINS; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MOTOR NEURONS; MUSCLE, SKELETAL; NERVE TISSUE PROTEINS; NEUROMUSCULAR JUNCTION; STATISTICS, NONPARAMETRIC; SYNAPSES; TRANSCRIPTION FACTORS;

EID: 78650169329     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.09.057     Document Type: Article

References (51)

1. Apparsundaram S., Ferguson S.M., Blakely R.D. Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter. Biochem Soc Trans 2001, 29:711-716.
2. Arber S., Han B., Mendelsohn M., Smith M., Jessell T.M., Sockanathan S. Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron 1999, 23:659-674.
3. Asawa T., Shindo M., Momoi H. Compound muscle action potentials during repetitive nerve stimulation. Muscle Nerve 2004, 29:724-728.
4. Barker L.A., Mittag T.W. Comparative studies of substrates and inhibitors of choline transport and choline acetyltransferase. J Pharmacol Exp Ther 1975, 192:86-94.
5. Bazalakova M.H., Blakely R.D. The high-affinity choline transporter: a critical protein for sustaining cholinergic signaling as revealed in studies of genetically altered mice. Handb Exp Pharmacol 2006, 175:525-544.
6. Bazalakova M.H., Wright J., Schneble E.J., McDonald M.P., Heilman C.J., Levey A.I., Blakely R.D. Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Genes Brain Behav 2007, 6:411-424.
7. Beeri R., Le Novere N., Mervis R., Huberman T., Grauer E., Changeux J.P., Soreq H. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J Neurochem 1997, 69:2441-2451.
8. Birks R., MacIntosh F. Acetylcholine metabolism of a sympathetic ganglion. Can J Physiol Pharmacol 1961, 39:787-827.
9. Bonzelius F., Zimmermann H. Recycled synaptic vesicles contain vesicle but not plasma membrane marker, newly synthesized acetylcholine, and a sample of extracellular medium. J Neurochem 1990, 55:1266-1273.
10. Brandon E.P., Lin W., D'Amour K.A., Pizzo D.P., Dominguez B., Sugiura Y., Thode S., Ko C.P., Thal L.J., Gage F.H., Lee K.F. Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice. J Neurosci 2003, 23:539-549.
11. Brandon E.P., Mellott T., Pizzo D.P., Coufal N., D'Amour K.A., Gobeske K., Lortie M., Lopez-Coviella I., Berse B., Thal L.J., Gage F.H., Blusztajn J.K. Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. J Neurosci 2004, 24:5459-5466.
12. Byun N., Delpire E. Axonal and periaxonal swelling precede peripheral neurodegeneration in KCC3 knockout mice. Neurobiol Dis 2007, 28:39-51.
13. Cole C.R., Blackstone E.H., Pashkow F.J., Snader C.E., Lauer M.S. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999, 341:1351-1357.
14. De Paepe B., De Bleecker J.L., Van Coster R. Histochemical methods for the diagnosis of mitochondrial diseases. Curr Protoc Hum Genet 2009, 63. 63:19.2.1-19.2.19.
15. English B.A., Appalsamy M., Diedrich A., Ruggiero A.M., Lund D., Wright J., Keller N.R., Louderback K.M., Robertson D., Blakely R.D. Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter. Am J Physiol Heart Circ Physiol 2010, 299:H799-H810.
16. Everett A.W., Ernst E.J. Increased quantal size in transmission at slow but not fast neuromuscular synapses of apolipoprotein E deficient mice. Exp Neurol 2004, 185:290-296.
17. Ferguson S.M., Bazalakova M., Savchenko V., Tapia J.C., Wright J., Blakely R.D. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc Natl Acad Sci U S A 2004, 101:8762-8767.
18. Ferguson S.M., Blakely R.D. The choline transporter resurfaces: new roles for synaptic vesicles?. Mol Interv 2004, 4:22-37.
19. Ferguson S.M., Savchenko V., Apparsundaram S., Zwick M., Wright J., Heilman C.J., Yi H., Levey A.I., Blakely R.D. Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci 2003, 23:9697-9709.
20. Fong S.W., McLennan I.S., McIntyre A., Reid J., Shennan K.I., Bewick G.S. TGF-beta2 alters the characteristics of the neuromuscular junction by regulating presynaptic quantal size. Proc Natl Acad Sci U S A 2010, 107:13515-13519.
21. Frick K.M., Burlingame L.A., Delaney S.S., Berger-Sweeney J. Sex differences in neurochemical markers that correlate with behavior in aging mice. Neurobiol Aging 2002, 23:145-158.
22. Gaffield M.A., Tabares L., Betz W.J. The spatial pattern of exocytosis and post-exocytic mobility of synaptopHluorin in mouse motor nerve terminals. J Physiol 2009, 587:1187-1200.
23. Gracz L.M., Wang W.C., Parsons S.M. Cholinergic synaptic vesicle heterogeneity: evidence for regulation of acetylcholine transport. Biochemistry 1988, 27:5268-5274.
24. Gras C., Amilhon B., Lepicard E.M., Poirel O., Vinatier J., Herbin M., Dumas S., Tzavara E.T., Wade M.R., Nomikos G.G., Hanoun N., Saurini F., Kemel M.L., Gasnier B., Giros B., El Mestikawy S. The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat Neurosci 2008, 11:292-300.
25. Haga T. Synthesis and release of (14 C) acetylcholine in synaptosomes. J Neurochem 1971, 18:781-798.
26. Hicks A., Fenton J., Garner S., McComas A.J. M wave potentiation during and after muscle activity. J Appl Physiol 1989, 66:2606-2610.
27. Kaja S., van de Ven R.C., van Dijk J.G., Verschuuren J.J., Arahata K., Frants R.R., Ferrari M.D., van den Maagdenberg A.M., Plomp J.J. Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya. Eur J Neurosci 2007, 25:2009-2020.
28. Krishnaswamy A., Cooper E. An activity-dependent retrograde signal induces the expression of the high-affinity choline transporter in cholinergic neurons. Neuron 2009, 61:272-286.
29. Lee C., Barnes A., Yang E., Katz R.L. Neuromuscular facilitation during train-of-four and tetanic stimulation in healthy volunteers: observations with half-refractory paired responses. Br J Anaesth 1977, 49:555-560.
30. Lentz M., Nielsen J.F. Post-exercise facilitation and depression of M wave and motor evoked potentials in healthy subjects. Clin Neurophysiol 2002, 113:1092-1098.
31. Lerman I., Harrison B.C., Freeman K., Hewett T.E., Allen D.L., Robbins J., Leinwand L.A. Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. J Appl Physiol 2002, 92:2245-2255.
32. Lightfoot J.T., Turner M.J., Debate K.A., Kleeberger S.R. Interstrain variation in murine aerobic capacity. Med Sci Sports Exerc 2001, 33:2053-2057.
33. Massett M.P., Berk B.C. Strain-dependent differences in responses to exercise training in inbred and hybrid mice. Am J Physiol Regul Integr Comp Physiol 2005, 288:R1006-R1013.
34. Misgeld T., Burgess R.W., Lewis R.M., Cunningham J.M., Lichtman J.W., Sanes J.R. Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase. Neuron 2002, 36:635-648.
35. Molenaar P.C. A relative weak leg muscle in the rolling Nagoya mouse as a model for LambertEaton myasthenic syndrome. J Neuroimmunol 2008, 201202:166-171.
36. Nakata K., Okuda T., Misawa H. Ultrastructural localization of high-affinity choline transporter in the rat neuromuscular junction: enrichment on synaptic vesicles. Synapse 2004, 53:53-56.
37. Oliveira L., Correia-de-Sa P. Dissociation between M1-facilitation of acetylcholine release and crosstalk with A2A- and M2-receptors on rat motoneurons. Signal Transduct 2006, 6:19-31.
38. Schwab R.S., Osserman K.E., Tether J.E. Treatment of myasthenia gravis; prolonged action with multiple-dose tablets of neostigmine bromide and mestinon bromide. JAMA 1957, 165:671-674.
39. Schwartz P., Vanoli E., Stramba-Badiale M., De Ferrari G., Billman G., Foreman R. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988, 78:969-979.
40. Shao X.M., Feldman J.L. Cholinergic neurotransmission in the preBotzinger complex modulates excitability of inspiratory neurons and regulates respiratory rhythm. Neuroscience 2005, 130:1069-1081.
41. Sussman J.D., Argov Z., McKee D., Hazum E., Brawer S., Soreq H. Antisense treatment for myasthenia gravis: experience with monarsen. Ann N Y Acad Sci 2008, 1132:283-290.
42. Thaler J., Harrison K., Sharma K., Lettieri K., Kehrl J., Pfaff S.L. Active suppression of interneuron programs within developing motor neurons revealed by analysis of homeodomain factor HB9. Neuron 1999, 23:675-687.
43. Vaseghi M., Shivkumar K. The role of the autonomic nervous system in sudden cardiac death. Prog Cardiovasc Dis 2008, 50:404-419.
44. Volpicelli-Daley L.A., Hrabovska A., Duysen E.G., Ferguson S.M., Blakely R.D., Lockridge O., Levey A.I. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Mol Pharmacol 2003, 64:1309-1316.
45. Wessler I., Kilbinger H. Release of [3H]acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation. Naunyn Schmiedebergs Arch Pharmacol 1986, 334:357-364.
46. Wessler I., Sandmann J. Uptake and metabolism of [3H]choline by the rat phrenic nerve-hemidiaphragm preparation. Naunyn Schmiedebergs Arch Pharmacol 1987, 335:231-237.
47. Wilson J.M., Hartley R., Maxwell D.J., Todd A.J., Lieberam I., Kaltschmidt J.A., Yoshida Y., Jessell T.M., Brownstone R.M. Conditional rhythmicity of ventral spinal interneurons defined by expression of the Hb9 homeodomain protein. J Neurosci 2005, 25:5710-5719.
48. Wood S.J., Slater C.R. Safety factor at the neuromuscular junction. Prog Neurobiol 2001, 64:393-429.
49. Woolf N.J. Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 1991, 37:475-524.
50. Wyatt R.M., Balice-Gordon R.J. Heterogeneity in synaptic vesicle release at neuromuscular synapses of mice expressing synaptopHluorin. J Neurosci 2008, 28:325-335.
51. Yu S.P., Van der Kloot W. Increasing quantal size at the mouse neuromuscular junction and the role of choline. J Physiol 1991, 433:677-704.